US 12,667,564 · Application 17/536,892 · Granted Jun 30, 2026
US 12,667,564
Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
Estimated expiration
March 2, 2027
175 days remaining
Earliest effective filing
Mar 2, 2007
+ 20 years
Mar 2, 2027
PTA +0d
Mar 2, 2027
TD applied
Mar 2, 2027
Final
Mar 2, 2027
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- November 29, 2021
- Earliest effective filing
- March 2, 2007
- Issue date
- June 30, 2026
- PTA
- 0 days
- Base expiry (before PTA)
- March 2, 2027
March 2, 2007 + 20 years = March 2, 2027
- Continuation of application 16/927,497, filed Jul 13, 2020
- Continuation of application 16/549,718, filed Aug 23, 2019
- Continuation of application 15/710,990, filed Sep 21, 2017
- Continuation of application 15/144,010, filed May 2, 2016
- Continuation of application 14/504,750, filed Oct 2, 2014
- Continuation of application 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
- National stage entry of application PCTUS2007005256, filed Mar 2, 2007
- National stage entry of application PCTUS2007005256, filed Mar 2, 2007
- Continuation of application 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
- National stage entry of application PCTUS2007005256, filed Mar 2, 2007
- Continuation of application 14/504,750, filed Oct 2, 2014
- Continuation of application 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
- National stage entry of application PCTUS2007005256, filed Mar 2, 2007
- Continuation of application 15/144,010, filed May 2, 2016
- Continuation of application 14/504,750, filed Oct 2, 2014
- Continuation of application 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
- National stage entry of application PCTUS2007005256, filed Mar 2, 2007
- Continuation of application 15/710,990, filed Sep 21, 2017
- Continuation of application 15/144,010, filed May 2, 2016
- Continuation of application 14/504,750, filed Oct 2, 2014
- Continuation of application 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
- National stage entry of application PCTUS2007005256, filed Mar 2, 2007
- Continuation of application 16/549,718, filed Aug 23, 2019
- Continuation of application 15/710,990, filed Sep 21, 2017
- Continuation of application 15/144,010, filed May 2, 2016
- Continuation of application 14/504,750, filed Oct 2, 2014
- Continuation of application 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
- National stage entry of application PCTUS2007005256, filed Mar 2, 2007
- PRO60/778,258 — Provisional — not used for base term
- PRO60/778,258 — Provisional — not used for base term
- PRO60/778,258 — Provisional — not used for base term
- PRO60/778,258 — Provisional — not used for base term
- PRO60/778,258 — Provisional — not used for base term
- PRO60/778,258 — Provisional — not used for base term
- PRO60/778,258 — Provisional — not used for base term
- PRO60/778,258 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to March 2, 2027
US 8,748,611· Application 13/294,546Capping patent
Processes for preparing morphinan-6-one products with low levels of alpha beta-unsaturated compounds
- Filing date
- Nov 11, 2011
- Earliest effective filing
- Mar 2, 2007
- Issue date
- Jun 10, 2014
- PTA
- +213 days
- Calculated expiration
- Oct 1, 2027
Continuation of 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
National stage entry of PCTUS2007005256, filed Mar 2, 2007
National stage entry of PCTUS2007005256, filed Mar 2, 2007
Mar 2, 2007 + 20y + 213d PTA = Oct 1, 2027
US 12,667,564· Application 17/536,892(from application 17/536,892)Capping patent
Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
- Filing date
- Nov 29, 2021
- Earliest effective filing
- Mar 2, 2007
- Issue date
- Jun 30, 2026
- PTA
- 0 days
- Calculated expiration
- Mar 2, 2027
Continuation of 16/927,497, filed Jul 13, 2020
Continuation of 16/549,718, filed Aug 23, 2019
Continuation of 15/710,990, filed Sep 21, 2017
Continuation of 15/144,010, filed May 2, 2016
Continuation of 14/504,750, filed Oct 2, 2014
Continuation of 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
National stage entry of PCTUS2007005256, filed Mar 2, 2007
National stage entry of PCTUS2007005256, filed Mar 2, 2007
Continuation of 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
National stage entry of PCTUS2007005256, filed Mar 2, 2007
Continuation of 14/504,750, filed Oct 2, 2014
Continuation of 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
National stage entry of PCTUS2007005256, filed Mar 2, 2007
Continuation of 15/144,010, filed May 2, 2016
Continuation of 14/504,750, filed Oct 2, 2014
Continuation of 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
National stage entry of PCTUS2007005256, filed Mar 2, 2007
Continuation of 15/710,990, filed Sep 21, 2017
Continuation of 15/144,010, filed May 2, 2016
Continuation of 14/504,750, filed Oct 2, 2014
Continuation of 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
National stage entry of PCTUS2007005256, filed Mar 2, 2007
Continuation of 16/549,718, filed Aug 23, 2019
Continuation of 15/710,990, filed Sep 21, 2017
Continuation of 15/144,010, filed May 2, 2016
Continuation of 14/504,750, filed Oct 2, 2014
Continuation of 11/915,606, filed Nov 27, 2007, issued as US 8,871,779
National stage entry of PCTUS2007005256, filed Mar 2, 2007
Mar 2, 2007 + 20y = Mar 2, 2027
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/536,892 · US 12,667,564
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,667,564: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12667564Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.